Article
Animal model for hepatitis C virus infection.
Uirusu - 1 Jan 2015
Tsukiyama-Kohara Kyoko, Kohara Michinori
Abstract excerpt
Hepatitis C virus (HCV) infects more than 170 million people in the world and chronic HCV infection develops into cirrhosis and hepatocellular carcinoma (HCC). Recently, the effective compounds have been approved for HCV treatment, the protease inhibitor and polymerase inhibitor (direct acting antivirals; DAA). DAA-based therapy enabled to cure from HCV infection. However, development of new drug and vaccine is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
